Sulazepam: Difference between revisions
Appearance
Content deleted Content added
Anypodetos (talk | contribs) No ATC code |
m Removing from Category:GABAA receptor positive allosteric modulators in subcat using Cat-a-lot |
||
(47 intermediate revisions by 31 users not shown) | |||
Line 1: | Line 1: | ||
{{short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Watchedfields = changed |
|||
⚫ | |||
| verifiedrevid = 447995075 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| ATC_suffix= |
|||
<!------- Clinical data--> |
|||
| ATC_supplemental= |
|||
| tradename = |
|||
⚫ | |||
| legal_CA = Schedule IV |
|||
| DrugBank= |
|||
⚫ | |||
⚫ | |||
| molecular_weight = 300.81 g/mol |
|||
<!------- Pharmacokinetic data--> |
|||
| bioavailability |
| bioavailability = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
| pregnancy_category = |
|||
⚫ | |||
<!------- Identifiers--> |
|||
| routes_of_administration= |
|||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
| ChemSpiderID = 16935 |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = NZ779Q5S0W |
|||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
| KEGG = D05942 |
|||
<!------- Chemical data--> |
|||
⚫ | |||
| smiles = ClC1=CC=C(N(C)C(CN=C2C3=CC=CC=C3)=S)C2=C1 |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChI = 1S/C16H13ClN2S/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3 |
|||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChIKey = MWGWTOPCKLQYEU-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Sulazepam''' |
'''Sulazepam''' is a [[benzodiazepine]] derivative. It is the [[thioamide]] derivative of [[diazepam]]. It is metabolised into [[diazepam]], [[desmethyldiazepam]] and [[temazepam|oxydiazepam]]{{Citation needed|date=June 2018}}. It has [[sedative]], [[muscle relaxant]], [[hypnotic]], [[anticonvulsant]] and [[anxiolytic]] properties like those of other benzodiazepines.<ref>{{Cite web | url = http://www.psychotropics.dk/moleculeView/default.aspx?ID=1444&Catalogtype=A&ChapterID=1&Thissortorder=41 | title = sulazepam | access-date = 29 December 2008 | year = 2003 | publisher = psychotropics.dk }}</ref><ref>{{cite journal | vauthors = Golovenko NI, Zin'kovskii VG | title = [Analysis of the structure of the components of the convulsive action of corazole following administration of sulazepam and its metabolites to mice] | language = ru | journal = Biulleten' Eksperimental'noi Biologii I Meditsiny | volume = 82 | issue = 9 | pages = 1078–81 | date = September 1976 | pmid = 11012 | trans-title = Analysis of the structure of the components of the convulsive action of corazole following administration of sulazepam and its metabolites to mice }}</ref> It was never marketed. |
||
== |
==Synthesis== |
||
[[File:Sulazepam synthesis.svg|thumb|center|400px|Sulazepam synthesis:<ref>{{cite journal|doi=10.1021/jo01024a511|title=Quinazolines and 1,4-Benzodiazepines. XVI. Synthesis and Transformations of 5-Phenyl-1,4-benzodiazepine-2-thiones |journal=The Journal of Organic Chemistry |volume=29 |pages=231 |year=1964| vauthors = Archer GA, Sternbach LH }}</ref> {{US Patent|3141890}}]] |
|||
*[[Benzodiazepine]] |
|||
Treatment of diazepam with [[phosphorus pentasulfide]] produces the corresponding [[thionamide]], sulazepam. |
|||
== See also == |
|||
*[[Uldazepam]] |
|||
==References== |
== References == |
||
{{Reflist}} |
|||
<references/> |
|||
{{Benzodiazepines}} |
{{Benzodiazepines}} |
||
{{GABAAR PAMs}} |
|||
[[Category:Benzodiazepines]] |
[[Category:Benzodiazepines]] |
||
[[Category: |
[[Category:Chloroarenes]] |
||
[[Category: |
[[Category:Thioamides]] |
||
[[Category:Hypnotics]] |
|||
[[Category:Sedatives]] |
|||
{{ |
{{sedative-stub}} |
Latest revision as of 07:39, 7 December 2023
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H13ClN2S |
Molar mass | 300.80 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Sulazepam is a benzodiazepine derivative. It is the thioamide derivative of diazepam. It is metabolised into diazepam, desmethyldiazepam and oxydiazepam[citation needed]. It has sedative, muscle relaxant, hypnotic, anticonvulsant and anxiolytic properties like those of other benzodiazepines.[1][2] It was never marketed.
Synthesis
[edit]Treatment of diazepam with phosphorus pentasulfide produces the corresponding thionamide, sulazepam.
See also
[edit]References
[edit]- ^ "sulazepam". psychotropics.dk. 2003. Retrieved 29 December 2008.
- ^ Golovenko NI, Zin'kovskii VG (September 1976). "[Analysis of the structure of the components of the convulsive action of corazole following administration of sulazepam and its metabolites to mice]" [Analysis of the structure of the components of the convulsive action of corazole following administration of sulazepam and its metabolites to mice]. Biulleten' Eksperimental'noi Biologii I Meditsiny (in Russian). 82 (9): 1078–81. PMID 11012.
- ^ Archer GA, Sternbach LH (1964). "Quinazolines and 1,4-Benzodiazepines. XVI. Synthesis and Transformations of 5-Phenyl-1,4-benzodiazepine-2-thiones". The Journal of Organic Chemistry. 29: 231. doi:10.1021/jo01024a511.